BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 17164588)

  • 1. Persistent and aggressive treatment for thymic carcinoma. Results of a single-institute experience with 25 patients.
    Maruyama R; Suemitsu R; Okamoto T; Kojo M; Aoki Y; Wataya H; Eguchi T; Nishiyama K; Seto T; Ichinose Y
    Oncology; 2006; 70(5):325-9. PubMed ID: 17164588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A single institutional experience of surgically resected thymic epithelial tumors over 10 years: clinical outcomes and clinicopathologic features.
    Kim BK; Cho BC; Choi HJ; Sohn JH; Park MS; Chang J; Kim SK; Kim DJ; Chung KY; Lee CG; Kim JH; Yoo NC
    Oncol Rep; 2008 Jun; 19(6):1525-31. PubMed ID: 18497960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of radiotherapy for thymic carcinoma.
    Nonaka T; Tamaki Y; Higuchi K; Katoh H; Nakahashi M; Horikoshi H; Takahashi K; Minato K; Sugihara S; Kojima M
    Jpn J Clin Oncol; 2004 Dec; 34(12):722-6. PubMed ID: 15640502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced stage thymomas and thymic carcinomas: results of multimodality treatments.
    Lucchi M; Ambrogi MC; Duranti L; Basolo F; Fontanini G; Angeletti CA; Mussi A
    Ann Thorac Surg; 2005 Jun; 79(6):1840-4. PubMed ID: 15919267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of base of tongue cancer with paclitaxel, ifosfamide, and cisplatinum induction chemotherapy followed by chemoradiotherapy.
    Hancock SB; Krempl GA; Canfield V; Bogardus C; Kojouri K; Kaneaster SK; Medina JE
    Laryngoscope; 2008 Aug; 118(8):1357-61. PubMed ID: 18528311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination chemotherapy with carboplatin and paclitaxel for advanced thymic cancer.
    Furugen M; Sekine I; Tsuta K; Horinouchi H; Nokihara H; Yamamoto N; Kubota K; Tamura T
    Jpn J Clin Oncol; 2011 Aug; 41(8):1013-6. PubMed ID: 21742653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel and cisplatin with concurrent radiotherapy followed by surgery in locally advanced thymic carcinoma.
    Fukuda M; Obase Y; Miyashita N; Kobashi Y; Mohri K; Ueno S; Hayama M; Shimizu K; Nishimura H; Nakata M; Oka M
    Anticancer Res; 2007; 27(3B):1601-4. PubMed ID: 17595782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction chemotherapy with paclitaxel plus carboplatin followed by paclitaxel with concurrent radiotherapy in stage IIIB non-small-cell lung cancer (NSCLC) patients: a phase II trial.
    Pallarés C; Capdevila J; Paredes A; Farré N; Ciria JP; Membrive I; Basterrechea L; Gomez-Segura G; Barnadas A
    Lung Cancer; 2007 Nov; 58(2):238-45. PubMed ID: 17658655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Concurrent chemoradiotherapy with vinorelbine and a platinum compound followed by consolidation chemotherapy for unresectable stage III non-small cell lung cancer: preliminary results of a phase II study.
    Rusu P; Ciuleanu TE; Cernea D; Pelau D; Gaal V; Cebotaru C; Guttman T; Todor N; Ghilezan N
    J BUON; 2007; 12(1):33-9. PubMed ID: 17436399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Long-term results of the surgical treatment for thymoma].
    Nakamura H; Tanaka Y; Horio H; Fukuda M; Hara H; Mori T
    Rinsho Kyobu Geka; 1994 Aug; 14(4):309-12. PubMed ID: 9423106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prospective non-randomized study of chemotherapy combined with radiotherapy versus chemotherapy alone in patients with metastatic or relapsed esophageal squamous cell carcinoma].
    Zhang XD; Shen L; Li J; Li Y; Li J; Zhang XT; Jin ML
    Zhonghua Zhong Liu Za Zhi; 2007 Jun; 29(6):474-7. PubMed ID: 17974288
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel prognostic groups in thymic epithelial tumors: assessment of risk and therapeutic strategy selection.
    D'Angelillo RM; Trodella L; Ramella S; Cellini N; Balducci M; Mantini G; Cellini F; Ciresa M; Fiore M; Evoli A; Sterzi S; Russo P; Grozio A; Cesario A; Granone P
    Int J Radiat Oncol Biol Phys; 2008 Jun; 71(2):420-7. PubMed ID: 18164843
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of adjuvant paclitaxel and carboplatin for advanced stage epithelial ovarian cancer: a population-based cohort study of all patients in western Sweden with long-term follow-up.
    Akeson M; Zetterqvist BM; Dahllöf K; Brännström M; Horvath G
    Acta Obstet Gynecol Scand; 2008; 87(12):1343-52. PubMed ID: 18951208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized phase 2 study of concomitant chemoradiotherapy using weekly carboplatin/paclitaxel with or without daily subcutaneous amifostine in patients with locally advanced head and neck cancer.
    Haddad R; Sonis S; Posner M; Wirth L; Costello R; Braschayko P; Allen A; Mahadevan A; Flynn J; Burke E; Li Y; Tishler RB
    Cancer; 2009 Oct; 115(19):4514-23. PubMed ID: 19634161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Feasibility of multimodality therapy including extended resections in stage IVA thymoma.
    Huang J; Rizk NP; Travis WD; Seshan VE; Bains MS; Dycoco J; Downey RJ; Flores RM; Park BJ; Rusch VW
    J Thorac Cardiovasc Surg; 2007 Dec; 134(6):1477-83; discussion 1483-4. PubMed ID: 18023668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multicentre phase II trial of paclitaxel and carboplatin with concurrent radiotherapy in locally advanced non-small cell lung cancer.
    Tell R; Sederholm C; Klintenberg C; Franksson L; Brandén E; Hillerdal G; Lönn U; Lindén CJ; Ewers SB; Lamberg K; Mrazek E; Lödén B; Sjögren A; Linné T; Friesland S; Sirzén F
    Anticancer Res; 2008; 28(5B):2851-7. PubMed ID: 19031924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined weekly carboplatin and paclitaxel as primary treatment of advanced epithelial ovarian carcinoma.
    Safra T; Menczer J; Bernstein RM; Shpigel S; Matcejevsky D; Inbar MJ; Golan A; Grisaru D; Levy T
    Gynecol Oncol; 2009 Aug; 114(2):215-8. PubMed ID: 19446318
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thymic carcinoma: a report of 13 cases.
    Lucchi M; Mussi A; Ambrogi M; Gunfiotti A; Fontanini G; Basolo F; Angeletti CA
    Eur J Surg Oncol; 2001 Nov; 27(7):636-40. PubMed ID: 11669591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome after combined modality treatment for uterine papillary serous carcinoma: a study by the Rare Cancer Network (RCN).
    Goldberg H; Miller RC; Abdah-Bortnyak R; Steiner M; Yildiz F; Meirovitz A; Villà S; Poortmans PM; Azria D; Zidan J; Ozsahin M; Abacioglu U; Gold DG; Amit A; Lavie O; Atahan IL; Kuten A;
    Gynecol Oncol; 2008 Feb; 108(2):298-305. PubMed ID: 18096209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The activity of carboplatin and paclitaxel for recurrent cervical cancer after definitive radiotherapy.
    Mabuchi S; Morishige K; Fujita M; Tsutsui T; Sakata M; Enomoto T; Kimura T
    Gynecol Oncol; 2009 May; 113(2):200-4. PubMed ID: 19268342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.